Paper Details
- Home
- Paper Details
An experimental study to evaluate safety/toxicity of intravitreal natalizumab.
Author: ChawlaRohan, MokshaLaxmi, NagTapas C, NathMadhu, VelpandianThirumurthy
Original Abstract of the Article :
PURPOSE: The purpose of this prospective experimental study was to evaluate the safety/toxicity of α4β1 integrin blockade in rabbit retina using its monoclonal antibody (Natalizumab). METHODS: Twelve New Zealand albino rabbits were divided into three groups (n = 4). Unilateral intravitreal injectio...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173036/
データ提供:米国国立医学図書館(NLM)
Natalizumab: Navigating the Safety Waters
Intravitreal injections, a common procedure for treating eye diseases, involve delivering medications directly into the vitreous humor, the gel-like substance filling the eye. Researchers must carefully evaluate the safety of these injections, particularly for new medications. This study investigates the safety and potential toxicity of intravitreal natalizumab, a monoclonal antibody used to treat multiple sclerosis.
A Careful Assessment
The study, a meticulous investigation into the safety of intravitreal natalizumab, revealed that low and intermediate doses of the medication appear safe for rabbit retinas. However, high-dose injections resulted in functional and anatomical changes in the retina, suggesting a potential for retinal toxicity at high concentrations.
A Dose of Caution
This research provides valuable insights into the safety of intravitreal natalizumab, highlighting the importance of careful dose selection and ongoing monitoring to minimize potential risks.
Dr.Camel's Conclusion
This study serves as a reminder that even in the seemingly calm waters of intravitreal injections, there can be hidden currents. The researchers have meticulously charted a course, providing valuable data for navigating the safety considerations of this therapeutic approach.
Date :
- Date Completed 2018-10-23
- Date Revised 2022-03-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.